US biopharma: "nearly 300 vaccines in R&D"

Article Date: 24/04/2012 06:00
US biopharma: "nearly 300 vaccines in R&D"

Vacancy Search

Quick job search

Advanced Search

Latest News

EU OK's Gilead's rare blood cancers drug

EU OK's Gilead's rare blood cancers drug

GSK slapped with £297m fine for China bribery charges

GSK slapped with £297m fine for China bribery charges

FDA approves Lilly's diabetes drug Trulicity

FDA approves Lilly's diabetes drug Trulicity

Last chance to enter PT Marketer of the Year

Last chance to enter PT Marketer of the Year

Upcoming events: Pivotal data for Seattle Genetics and Erytech

Welcome to your weekly digest of approaching regulatory and clinical readouts. By October, Seattle Genetics will reveal interim data from a phase III trial called Aethera, testing Adcetris...

Europe okays Novo Nordisk diabetes combo Xultophy

Europe okays Novo Nordisk diabetes combo Xultophy

Lilly's Cyramza shows survival benefit in gastro cancers

Lilly's Cyramza shows survival benefit in gastro cancers

FDA OKs fast-action erectile dysfunction drug Stendra

FDA OKs fast-action erectile dysfunction drug Stendra

Pharma needs to engage more digitally with docs

Pharma needs to engage more digitally with docs

Bayer pharma R&D spend to rise after plastics spin-off

Bayer pharma R&D spend to rise after plastics spin-off
more news